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uccessful myocardial recovery in patients with end-stage
heart failure after left ventricular assist device (LVAD)
support combined with pharmacologic therapy is fre-
quently encountered in our institution.1 Minor surgical
trauma in explanting ventricular assist devices (VADs) from recov-
ered patients plays an important role in a successful bridge-to-recov-
ery procedure.2,3 We report a minimally invasive technique for
explanting the HeartMate II LVAD (ThermoCardiosystems, Inc,
Woburn, Mass).
Clinical Summary
The technique consists of a small (approximately 5 cm) left antero-
lateral thoracotomy through the fifth intercostal space, followed by
a small right anterior parasternal thoracotomy (approximately 4 cm)
through the second intercostal space and a small superior epigastric
From Cardiothoracic Transplantation and Mechanical Circulatory Support,
Royal Brompton and Harefield Hospital, National Heart and Lung Insti-
tute, Imperial College for Science, Technology and Medicine, London,
United Kingdom.
Received for publication Aug 17, 2007; revisions received Oct 5, 2007;
accepted for publication Oct 15, 2007.
Address for reprints: Asghar Khaghani, FRCS, Cardiothoracic Transplanta-
tion and Mechanical Circulatory Support, Royal Brompton and Harefield
Hospital NHS Trust, Hill End Rd, Harefield, Middlesex, London UB9 6JH,
United Kingdom (E-mail: S.Haj-Yahia@imperial.ac.uk).
J Thorac Cardiovasc Surg 2008;135:453-4
0022-5223/$34.00
Copyright  2008 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.10.012The Journal of Thoincision (approximately 5 cm) dissecting and exposing the apex, the
outflow joints, and the body of the device, respectively (Figure 1).
Cardiopulmonary bypass (CPB) is established through arterial can-
nulation in the LVAD outflow line and femoral vein cannulation for
venous return (Figure 1, B). The VAD is switched off, the outflow
line is clamped below the CPB arterial cannulation site, and the heart
is fibrillated after beginning CPB.
At this stage, the inflow cannula is removed from the left ventri-
cle, the apex is oversewn, and the heart is defibrillated externally or
internally. After weaning the patient from CPB support with ino-
tropes and nitric oxide routinely, the CPB cannulae are removed,
and the outflow Dacron graft is divided and oversewn proximal to
the aorta, leaving a stump of less than 1 cm (Figure 2, A). The inflow
component of the VAD is dismantled from the main pump, the
driveline is divided close to the main device, and then both are re-
moved through the epigastric incision (Figure 2, B). To avoid con-
tamination, the power cable driveline is removed only after the
closure of all incisions, leaving the driveline exit site open to drain
(Figure 2, B).
Two patients with HeartMate II LVADs implanted for dilated
cardiomyopathy received our combination of LVAD and pharmaco-
logic therapy,1 resulting in sufficient myocardial recovery to allow
explantation of the device by using this limited surgical approach
technique. Both were male; ages at explantation were 19 and 42
years, respectively; and the duration of mechanical circulatory sup-
port was 156 and 205 days, respectively. The postoperative course
was uneventful, with a 100% survival rate. The mean postoperative
ventilation time, intensive care unit length of stay, and hospital stay
were 30 hours, 4 days, and 14 days, respectively. The total postop-
erative blood loss until drains were removed was 467 mL. The num-
ber of blood units and amounts of fresh frozen plasma, platelets, and
cryoprecipitate administered were 3.5, 1.5, 1, and 0, respectively.A B
Figure 1. A, Demonstration of the dis-
section and exposure of the inflow
and outflow tubes and pump. B, Estab-
lishment of cardiopulmonary bypass
through the left ventricular assist de-
vice outflow line and femoral venous
cannulation for arterial and venous
return, respectively.racic and Cardiovascular Surgery c Volume 135, Number 2 453
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Figure 2. A, Removal of the inflow
cannula and oversewing of the apex,
followed by dismantling the outflow
from the main pump and snipping off
the power cable lead close to the
pump. B, The outflow Dacron line is
divided and oversewn proximal to the
aorta. The inflow line is dismantled
from the main pump, and both are re-
moved through the epigastric incision.
The power cable driveline is removed
only after the closure of all incisions,
leaving the driveline exit site open to
drain.There was no incidence of wound infection or any other
complications.
Discussion
Removing LVADs after myocardial recovery can be very difficult
and challenging because of dense mediastinal adhesions and the
risk of surgical trauma during the dissection, which can be very
damaging to the recovered heart. Additionally, a full sternotomy
and mobilization of the heart can cause excessive bleeding, requir-
ing more blood and blood products, which might affect the pulmo-
nary vascular resistance and subsequently might be detrimental to
the right ventricular function.
For that reason, we think that the avoidance of median sternot-
omy and mobilization of the heart by limiting the surgical approach
contributes to the success of the bridge to recovery and has im-
proved our final results.1 It also can facilitate the patient’s postoper-
ative recovery and mobilization.454 The Journal of Thoracic and Cardiovascular Surgery c FeThe HeartMate II LVAD can be explanted by using a minimally
invasive surgical technique. This procedure might play an important
role in explant success, maintaining good ventricular function and
reducing complications in recovered patients with LVADs.
We thank the Harefield VAD team for their help in data collec-
tion and their dedicated care to all patients receiving VADs.
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